Clive A. Meanwell's Insider Trades & SAST Disclosures

Clive A. Meanwell's most recent trade in Fractyl Health Inc. was a trade of 596,352 Series F Preferred Stock done . Disclosure was reported to the exchange on Feb. 6, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Fractyl Health Inc.
Clive A. Meanwell Director 06 Feb 2024 596,352 0 - - Series F Preferred Stock
Fractyl Health Inc.
Clive A. Meanwell Director 06 Feb 2024 277,890 277,890 - - Common Stock
Fractyl Health Inc.
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Invivyd Inc
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 50,000 50,000 - - Stock Option (Right to Buy)
EQRx Inc
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2023 226 43,172 - - Earn-out Shares
EQRx Inc
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2022 101,010 101,010 - - Stock Option (Right to Buy)
Invivyd Inc
Clive A. Meanwell Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 150,000 150,000 - - Stock Option (Right to Buy)
EQRx Inc
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2021 313,500 313,500 - - Stock Option (Right to Buy)
EQRx Inc
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2021 42,946 42,946 - - Earn-out Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades